Cells process dynamic signaling inputs to regulate fate decisions during development. While oscillations or waves in key developmental pathways, such as Wnt, have been widely observed, the principles ...

Lantern Pharma Inc. , a clinical-stage biopharmaceutical company leveraging its proprietary RADR® artificial intelligence platform to transform oncology drug discovery and development, today announced ...

Reviewers viewed the targeting of TFAM as innovative and the study's conclusions as potentially important (especially the effects on inflammation). However, the lack of evidence for a direct effect of ...

Data from the Phase 1 CARLYSLE study in severe refractory systemic lupus erythematosus (srSLE) suggests obe-cel is well tolerated with no ICANS ...

Phase 3 study presentations in SLE to show efficacy results across multiple clinical endpoints, including low disease ...

Objectives Patients with primary Sjögren’s disease (SjD) have an increased risk of B cell lymphoma. The aim of this study was ...

AlphaTON Capital Corp (Nasdaq: ATON) and its wholly owned oncology-focused subsidiary Tarus Therapeutics, LLC, operating as Cyncado Therapeutics (Cyncado), today issued a recap of data presented on ...

He concluded that numerous KDA projects worth billions of rupees are currently underway, all funded by the Sindh Government. ...

Data demonstrates sustained clinical improvements in pain, stiffness and function for up to 156 weeks following a single administration of ...

Clubroot disease, caused by Plasmodiophora brassicae, is a devastating soil-borne pathogen that severely threatens global ...

The sixth European Society of Clinical Microbiology and Infectious Diseases Conference on Vaccines took place in Lisbon, ...

Metabolism guides the activation states of regulatory T cells, the immune cells that prevent inappropriate activation of the ...